CH510674A - Verfahren zur Herstellung von Salzen der Dihydro-orotsäure mit primären, sekundären oder tertiären Aminen - Google Patents

Verfahren zur Herstellung von Salzen der Dihydro-orotsäure mit primären, sekundären oder tertiären Aminen

Info

Publication number
CH510674A
CH510674A CH1891168A CH1891168A CH510674A CH 510674 A CH510674 A CH 510674A CH 1891168 A CH1891168 A CH 1891168A CH 1891168 A CH1891168 A CH 1891168A CH 510674 A CH510674 A CH 510674A
Authority
CH
Switzerland
Prior art keywords
dihydro
salts
primary
preparation
tertiary amines
Prior art date
Application number
CH1891168A
Other languages
German (de)
English (en)
Inventor
Wilhelm Pfirrmann Rolf
Hofstetter Emil
Original Assignee
Geistlich Soehne Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geistlich Soehne Ag filed Critical Geistlich Soehne Ag
Publication of CH510674A publication Critical patent/CH510674A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1891168A 1967-12-21 1968-12-19 Verfahren zur Herstellung von Salzen der Dihydro-orotsäure mit primären, sekundären oder tertiären Aminen CH510674A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5814067A GB1182320A (en) 1967-12-21 1967-12-21 Dihydroorotic and Salts

Publications (1)

Publication Number Publication Date
CH510674A true CH510674A (de) 1971-07-31

Family

ID=10480857

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1891168A CH510674A (de) 1967-12-21 1968-12-19 Verfahren zur Herstellung von Salzen der Dihydro-orotsäure mit primären, sekundären oder tertiären Aminen

Country Status (7)

Country Link
BE (1) BE725874A (xx)
CH (1) CH510674A (xx)
DE (1) DE1816097A1 (xx)
ES (1) ES361702A1 (xx)
FR (1) FR8234M (xx)
GB (1) GB1182320A (xx)
NL (1) NL6818217A (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3912477A1 (de) * 1989-04-15 1990-10-18 Mueller Robert Dr Aeusserlich anzuwendendes praeparat und seine verwendung
US7396526B1 (en) 1998-11-12 2008-07-08 Johnson & Johnson Consumer Companies, Inc. Skin care composition
US6607735B2 (en) 2000-12-21 2003-08-19 Johnson & Johnson Consumer Companies, Inc. Method for reducing the appearance of dark circles under the eyes
US20040254202A1 (en) * 2003-06-13 2004-12-16 The Procter & Gamble Company Method of promoting sleep using topical administration of vasoactive agents

Also Published As

Publication number Publication date
DE1816097A1 (de) 1969-09-25
ES361702A1 (es) 1970-11-16
NL6818217A (xx) 1969-06-24
FR8234M (xx) 1970-09-28
GB1182320A (en) 1970-02-25
BE725874A (xx) 1969-06-20

Similar Documents

Publication Publication Date Title
AT281778B (de) Verfahren zur Herstellung von Alk-3-en-1-olen
CH479559A (de) Verfahren zur Herstellung von Acylguanidinen
CH489510A (de) Verfahren zur Herstellung von substituierten v-Triazolen
AT283594B (de) Verfahren zur Herstellung von 7-Halogen-octopyranosiden
AT279602B (de) Verfahren zur Herstellung von Pyrrol-3-yl-ketonen
CH498142A (de) Verfahren zur Herstellung von substituierten Piperidino-alkylthianaphthenen und -benzofuranen
DE1772680B2 (de) Verfahren zur photographischen herstellung von masken
CH526524A (de) Verfahren zur Herstellung von 6a,6B-Difluorsteroiden
AT283357B (de) Verfahren zur Herstellung von 2-Aryl-v-triazolen
CH483425A (de) Verfahren zur Herstellung von p-Alkoxy-piperidin-amiden
CH510674A (de) Verfahren zur Herstellung von Salzen der Dihydro-orotsäure mit primären, sekundären oder tertiären Aminen
CH525173A (de) Verfahren zur Herstellung von 3-Methylbut-2-en-1-ol oder 3-Methylbut-2-en-1-ylacetat
CH507930A (de) Verfahren zur Herstellung von 5-Methyl-4-hydroxy-2,3-dihydrofuran-3-on
CH484930A (de) Verfahren zur Herstellung von Aryloxazolen
AT286293B (de) Verfahren zur Herstellung von neuen Styrylthiazoliumsalzen
CH500935A (de) Verfahren zur Herstellung von Phenylsalicylsäure-Verbindungen
CH500232A (de) Verfahren zur Herstellung von Alkylthionophosphonsäuredichloriden
AT281420B (de) Verfahren zur Herstellung von α-Triorganosiloxy-ω-hydroxy-diorganopolysiloxanen
AT289295B (de) Verfahren zur Herstellung von wasserlöslichen Salzen von α-Aminobenzylpenicilin
CH503765A (de) Verfahren zur Herstellung von Dihalogeniden der halogenvinylphosphorigen Säure
CH493552A (de) Verfahren zur Herstellung von 3-Oxo-5-chlor-1,2,4-thiadiazolinium-Salzen
AT282603B (de) Verfahren zur Herstellung von Hydroxybenzonitrilen
AT281007B (de) Verfahren zur Herstellung von Hydroxybenzonitrilen
AT280309B (de) Verfahren zur Herstellung von 3-Methansulfonylphenthiazinen
CH431542A (de) Verfahren zur Herstellung von Mercapto-pyridazin-N-oxyden oder deren Salze

Legal Events

Date Code Title Description
PL Patent ceased